Suppr超能文献

每日或隔日给予低剂量利尿剂吲达帕胺对血压和代谢参数的影响。

Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters.

作者信息

Inaba Munemichi, Noguchi Yuichi, Yamamoto Taro, Imai Tomihiko, Hatano Masako, Yagi Shinji, Katayama Shigehiro

机构信息

Fourth Department of Medicine, Saitama Medical School, 38 Morohongo, Moroyama-cho, Iruma-gun, Saitama 350-0495, Japan.

出版信息

Hypertens Res. 2004 Mar;27(3):141-5. doi: 10.1291/hypres.27.141.

Abstract

To investigate the effects of the diuretic, indapamide, on blood pressure (BP) and metabolic parameters, thirty hypertensive patients were treated with 1 mg of indapamide either every day or every other day. BP, fasting plasma glucose, lipids, serum potassium and uric acid were determined at baseline and after 3 months of a stable regimen of the drug. At the termination of the study, 48-h ambulatory blood pressure monitoring (ABPM) was performed. Three patients received only indapamide, while other patients were treated in combination with additional antihypertensive medications. Patients treated with daily indapamide showed a BP reduction from 162 +/- 2.9/85 +/- 2.4 mmHg to 134 +/- 2.4/71 +/-2.6 mmHg (p < 0.001). The BP reduction was similar in those patients receiving the drug every other day (137 +/- 3.4/71 +/- 3.6 mmHg). While plasma lipids and serum potassium did not differ significantly with the intervention, uric acid increased significantly with daily treatment and normalized with every-other-day treatment. Glycosylated hemoglobin A1c (HbA1c) was not altered (5.6 +/- 0.1% vs. 5.4 +/- 0.2%), and did not differ between patients with and without diabetes mellitus. ABPM revealed an average 24-h BP of 134 +/- 3.3/75 +/- 1.7 mmHg on days in which patients received the medication and 139 +/- 4.9/78 +/- 2.6 mmHg on the intervening day without indapamide (no significant difference). These results suggest that a low dose of indapamide given every day or every other day is effective in lowering BP and does not result in metabolic derangements.

摘要

为研究利尿剂吲达帕胺对血压(BP)和代谢参数的影响,30例高血压患者每天或隔天服用1mg吲达帕胺进行治疗。在基线期以及药物稳定治疗3个月后,测定血压、空腹血糖、血脂、血清钾和尿酸。研究结束时,进行了48小时动态血压监测(ABPM)。3例患者仅接受吲达帕胺治疗,其他患者则联合使用其他抗高血压药物进行治疗。每日服用吲达帕胺的患者血压从162±2.9/85±2.4mmHg降至134±2.4/71±2.6mmHg(p<0.001)。隔天服用该药的患者血压下降情况相似(137±3.4/71±3.6mmHg)。虽然干预后血脂和血清钾无显著差异,但每日治疗后尿酸显著升高,隔天治疗后尿酸恢复正常。糖化血红蛋白A1c(HbA1c)未改变(5.6±0.1%对5.4±0.2%),糖尿病患者与非糖尿病患者之间也无差异。ABPM显示,患者服药日的平均24小时血压为134±3.3/75±1.7mmHg,未服用吲达帕胺的间隔日平均血压为139±4.9/78±2.6mmHg(无显著差异)。这些结果表明,每天或隔天给予低剂量吲达帕胺可有效降低血压,且不会导致代谢紊乱。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验